Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
A Phase 3 Extension, Multicenter, Double-Blind, Long Term Safety and Tolerability Treatment Trial of Bapineuzumab (ABB-001, ELN115727) in Subjects with Alzheimer's Disease who Participated in Study ELN115727-301 or in Study ELN115727-302
Knebl, Janice
(PI)
Texas College of Osteopathic Medicine
Internal Medicine & Geriatrics
Institute for Healthy Aging
Overview
Project Details
Status
Finished
Effective start/end date
4/05/10
→
31/12/13
Funding
Janssen Pharmaceuticals:
$89,721.88
View all
View less
Keywords
Aging & Alzheimers, Biotechnology & Drug Development